Background

I am an infectious diseases physician and completed my advanced training at the Alfred and Geelong Hospital.

Since obtaining my fellowship I have been working at Barwon Health and teaching at Deakin University.

I have an interest in blood borne viruses and sexually transmitted infections, and have been working in the sexual health and liver clinics at Barwon Health for some years.

Recently I have undertaken managing the liver clinic, which provides viral hepatitis services to the area.

My research topic is models of care for hepatitis C in the era of directly acting antivirals and Margaret Hellard is my primary supervisor.

My ultimate goal is to increase hepatitis C service provision for those in regional and rural areas.

Positions

• Director, Liver clinic, Barwon Health

• Infectious Diseases physician, Barwon Health

Qualifications

• MBBS (Hons), Monash, 1999

• FRACP (Infectious Diseases), 2008

Projects (1)

Current (1)

• The Prime Study: Treating hep C in primary healthcare setting
  Examining feasibility of treating people with genotype 1 hepatitis C in primary healthcare setting.

Publications (13)

2018 (4)

• Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial.
  Wade AJ, Doyle JS, Gane E, Stedman C, Draper B, Iser D, Roberts SK, Kemp W, Petrie D, Scott N, Higgs P, Agius PA, Roney J, Stothers L, Thompson AJ, Hellard ME
  Trials. 2018 Jul; 19(1):383
• Health issues of refugees attending an infectious disease refugee health clinic in a regional Australian hospital
  Masters PJ, Lanfranco PJ, Sneath E, Wade AJ, Huffam S, Pollard J, Standish J, McCloskey K, Athan E, O'Brien DP, Friedman ND
  Aust J Gen Pract. 2018 May; 47(5):305-310
• Aiming for elimination: outcomes of a consultation pathway supporting regional general practitioners to prescribe direct acting antiviral therapy for hepatitis C.
  Wade AJ, McCormack A, Roder C, McDonald K, Davies M, Scott N, Wardrop M, Athan E, Hellard ME
  J Viral Hepat. 2018 Apr; 25(9):1089-1098
• Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access.
  Scott N, Hainsworth SW, Sacks-Davis R, Pedrana A, Doyle J, Wade A, Hellard M
  J Virus Erad. 2018 Apr; 4(2):108-114

2017 (1)

• A survey of hepatitis C management by Victorian GPs after PBS-listing of direct-acting antiviral therapy.
  Wade A, Draper B, Doyle J, Allard N, Grinzi P, Thompson A, Hellard M
  Aust Fam Physician. 2017 Apr; 46(4):235-240

2016 (1)

• A systematic review of community based hepatitis C treatment.
  Wade AJ, Veronese V, Hellard ME, Doyle JS.
  BMC Infect Dis. 2016 May; 16(1):202

2015 (1)

• The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service.
  Wade AJ, Macdonald DM, Doyle JS, Gordon A, Roberts SK, Thompson AJ, Hellard ME
  PLoS One. 2015 Nov; 10(11):e0142770

2010 (1)

• Ribavirin and Viramidine (Book Chapter)
  Wade AJ, Sasadeausz J
  in Kucers’ The Use of Antibiotics, 6th Edition, Hodder-Arnold. 2010 Jul

2007 (2)

• Chlamydia trachomatis prevalence in heterosexual men in Melbourne: a community-based study.
  Wade AJ, Hocking LS, Hellard ME
  Sex Health. 2007 Jun; 4(2):137-138
• Leptospirosis: an unusual presentation.
  Amanda J Wade, David V Tuxen, Steven L Wesselingh
  Crit Care Resusc. 2007 Mar; 9(1):108

2006 (3)

• Postoperative enteritis due to methicillin-resistant Staphylococcus aureus.
  Allenc Cheng, Amanda Wade, Owenc Harris, Conrad Brandt, Eugene Athan
  ANZ J Surg. 2006 Aug; 76(8):763
• Spontaneous splenic rupture: a rare complication of Q fever in Australia.
  Amanda J Wade, Tim Walker, Eugene Athan, Andrew J Hughes
  Med J Aust. 2006 Apr; 184(7):364
• Q fever outbreak at a cosmetics supply factory.
  Amanda J Wade, Allen C Cheng, Eugene Athan, Jo L Molloy, Owen C Harris, John Stenos, Andrew J Hughes
  Clin Infect Dis. 2006 Apr; 42(7):e50-e52